Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Banks working on the SpaceX IPO reportedly have to subscribe to Grok
Cutthroat capitalism sure does bring out the best in humanity. Take, for example, Elon Musk. He reportedly set a condition for banks, law firms, auditors and advisors who want to work on the SpaceX IP [...]
Viking Therapeutics closer to bringing its Ozempic competitor to market
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]
€19bn Visma picks London for tech IPO in rare win for UK stock market
Norwegian software firm Visma has provisionally picked London for its IPO next year. It could mark a rare win for the UK’s troubled stock market — if Downing Street pulls through on its promised r [...]
Fervo Energy launches $1.33bn IPO, the largest climate-tech listing of 2026
On Monday, Fervo Energy formally launched its IPO roadshow, offering 55,555,555 shares of Class A common stock at an indicated range of $21 to $24 each. At the high end of the range, the geothermal-en [...]